v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   159,602,069      
Beginning balance at Dec. 31, 2024 $ 117,651 $ 16 $ 472,331 $ (32) $ (354,664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon net exercise of stock options (in shares)   281,709      
Issuance of common stock upon net exercise of stock options 20   20    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,389,364      
Issuance of common stock upon vesting of restricted stock units 0        
Stock-based compensation cost 5,125   5,125    
Cumulative translation adjustment (46)     (46)  
Net loss (1,689)       (1,689)
Ending balance (in shares) at Mar. 31, 2025   163,273,142      
Ending balance at Mar. 31, 2025 121,061 $ 16 477,476 (78) (356,353)
Beginning balance (in shares) at Dec. 31, 2025   175,399,488      
Beginning balance at Dec. 31, 2025 $ 119,422 $ 18 507,347 (141) (387,802)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon net exercise of stock options (in shares) 482,435 482,435      
Issuance of common stock upon net exercise of stock options $ 322   322    
Issuance of common stock upon vesting of restricted stock units (in shares)   3,576,310      
Issuance of common stock upon vesting of restricted stock units 0        
Stock-based compensation cost 5,911   5,911    
Cumulative translation adjustment 28     28  
Net loss (5,009)       (5,009)
Ending balance (in shares) at Mar. 31, 2026   179,458,233      
Ending balance at Mar. 31, 2026 $ 120,674 $ 18 $ 513,580 $ (113) $ (392,811)